Are patients with high-normal platelet counts at increased risk of cancer?

Our previous work found that cancer risk was greatly increased for people with clinically high platelets (cells in the blood that enable clotting). The NORMA study will investigate whether people with platelet counts at the high end of the normal range are also at increased risk of cancer.

Aids to cancer diagnosis in primary care

This study is part of a wider Health and Technology Assessment study whose overall aim is to understand the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care.